Notice of Extension of PAR-20-299, "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)"
Notice Number:
NOT-HD-22-030

Key Dates

Release Date:

July 26, 2022

Related Announcements

PAR-20-299 - "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)"

Issued by

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Purpose

This Notice extends the expiration date for PAR-20-299, "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)" by one receipt cycle. The key dates have been modified.

Changes to Key Dates apply to Part 1. Overview Information, Key Dates.

Current Expiration Date: December 10, 2022

New Expiration Date: April 12, 2023

Changes are reflected in italics as follows:

Part 1. Overview Information

Key Dates

Currently reads:

Application Due Date(s): December 10, 2020, April 9, 2021, August 10, 2021, December 10, 2021, April 11, 2022, August 10, 2022, December 9, 2022

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s): Not Applicable

Scientific Merit Review: March 2021, July 2021, November 2021, March 2022, July 2022, November 2022, March 2023

Advisory Council Review: May 2021, October 2021, January 2022, May 2022, October 2022, January 2023, May 2023

Earliest Start Date: July 2021, December 2021, April 2022, July 2022, December 2022, April 2023, July 2023

Expiration Date: December 10, 2022

Modified to read (in italics)

Part 1. Overview Information,

Key Dates

Application Due Date(s): December 10, 2020, April 9, 2021, August 10, 2021, December 10, 2021, April 11, 2022, August 10, 2022, December 9, 2022, April 11, 2023

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review: March 2021, July 2021, November 2021, March 2022, July 2022, November 2022, March 2023, July 2023

Advisory Council Review: May 2021, October 2021, January 2022, May 2022, October 2022, January 2023, May 2023, October 2023

Earliest Start Date: July 2021, December 2021, April 2022, July 2022, December 2022, April 2023, July 2023, December 2023

Expiration Date: April 12, 2023

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Katie Vance, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-435-6640
Email: Katie.Vance@nih.gov